Companies Major investors unconcerned about GSK’s lack of payout for mother and baby home survivors Some smaller sustainability specialists are engaging with the pharmaceutical giant but there is unlikely to be a major fallout
GSK to offer ‘enhanced information service’ for mother and baby home survivorsThe pharmaceutical giant said it will simplify its information requests service available to those upon whom it conducted unethical pharmaceutical trials
GSK declines to apologise for vaccine trials in mother and baby homesPharma giant’s own documents show it conducted seven trials at homes over almost four decades